VIGIL NEUROSCIENCE, INC.

Analyst Reco. Vigil Neuroscience, Inc.

Equities

VIGL

US92673K1088

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
3.63 ^USD	+1.11%		+2.54%	+7.40%

May. 07	Vigil Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 17	Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wedbush Trims Vigil Neuroscience Price Target to $22 From $23, Maintains Outperform Rating	Mar. 26	MT
Morgan Stanley Downgrades Vigil Neuroscience to Underweight From Equalweight, Cuts Price Target to $4 From $13	Dec. 19	MT
JMP Securities Starts Vigil Neuroscience With Market Outperform Rating, Price Target is $23	23-10-18	MT
Mizuho Adjusts Price Target on Vigil Neuroscience to $13 From $15, Keeps Buy Rating	23-08-10	MT
Mizuho Initiates Vigil Neuroscience at Buy With $15 Price Target	23-03-31	MT
Morgan Stanley Adjusts Vigil Neuroscience Price Target to $13 From $12, Maintains Equal Weight Rating	23-03-27	MT
Morgan Stanley Adjusts Price Target on Vigil Neuroscience to $12 From $11, Maintains Equalweight Rating	22-11-14	MT
Guggenheim Trims Price Target on Vigil Neuroscience to $19 From $22, Maintains Buy Rating	22-11-11	MT
Wedbush Trims Vigil Neuroscience's Price Target to $23 From $24 on Higher Share Count, Keeps Outperform Rating	22-11-11	MT
Wedbush Starts Vigil Neuroscience at Outperform With $19 Price Target	22-09-16	MT
HC Wainwright Starts Vigil Neuroscience at Buy With $24 Price Target	22-08-29	MT
Morgan Stanley Lowers Vigil Neuroscience's Price Target to $11 From $17, Maintains Equalweight Rating	22-05-17	MT
Morgan Stanley Starts Vigil Neuroscience at Equalweight With $17 Price Target	22-02-01	MT
Guggenheim Starts Vigil Neuroscience at Buy With $23 Price Target	22-02-01	MT
Stifel Starts Vigil Neuroscience at Buy With $24 Price Target	22-02-01	MT
Jefferies Starts Vigil Neuroscience at Buy With $20 Price Target	22-02-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer